(Q34798909)

4 August 2017

title

Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy (English)

1 reference

4 August 2017

1 reference

schizoaffective disorder

1 reference

13

Philip D Harvey

1 reference

4 August 2017

Joseph I Friedman

1

1 reference

4 August 2017

Jean-Pierre Lindenmayer

2

1 reference

4 August 2017

Frances Alcantara

3

1 reference

4 August 2017

Stephanie Bowler

4

1 reference

4 August 2017

Mohan Parak

5

1 reference

4 August 2017

Leonard White

6

1 reference

4 August 2017

Adel Iskander

7

1 reference

4 August 2017

Michael Parrella

8

1 reference

4 August 2017

David N Adler

9

1 reference

4 August 2017

Nicholas D Tsopelas

10

1 reference

4 August 2017

Wei-Yann Tsai

11

1 reference

4 August 2017

Vladan Novakovic

12

1 reference

4 August 2017

Kenneth L Davis

14

1 reference

4 August 2017

Saurabh Kaushik

15

1 reference

4 August 2017

language of work or name

English

0 references

publication date

23 February 2011

1 reference

4 August 2017

published in

Neuropsychopharmacology

1 reference

4 August 2017

volume

36

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

1289-1295

1 reference

https://scigraph.springernature.com/pub.10.1038/npp.2011.14

4 August 2017

exact match

0 references

cites work

Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

8 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

8 July 2018

https://api.crossref.org/works/10.1038%2FNPP.2011.14

Clozapine alone versus clozapine and risperidone with refractory schizophrenia

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

A double-blind controlled study of adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clinical effects of clozapine in chronic schizophrenia: response to treatment and predictors of outcome

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Plasma clozapine levels and clinical response for treatment-refractory schizophrenic patients.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Delusions of infestation treated by pimozide: a double-blind crossover clinical study

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clozapine in China: a review and preview of US/PRC collaboration

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clinical and biologic response to clozapine in patients with schizophrenia. Crossover comparison with fluphenazine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Butyrophenone influences on the opiate receptor.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Letter: Pimozide in monosymptomatic psychosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Dopamine autoreceptors: pharmacology, function and comparison with post-synaptic dopamine receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Dopaminergic neurons: An in vivo system for measuring drug interactions with presynaptic receptors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Clozapine augmented with risperidone in the treatment of schizophrenia: a randomized, double-blind, placebo-controlled trial

8 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2011.14

SLOF: a behavioral rating scale for assessing the mentally ill.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2011.14

Sulpiride adjunction to clozapine in treatment-resistant schizophrenic patients: a preliminary case series study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNPP.2011.14

Plasma clozapine concentrations predict clinical response in treatment-resistant schizophrenia.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3077468

Risperidone augmentation for schizophrenia partially responsive to clozapine: a double-blind, placebo-controlled trial

26 October 2018

1 reference

12 December 2020

Treatment of Gilles de la Tourette syndrome with pimozide

1 reference

12 December 2020

Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking

1 reference

12 December 2020

Letter: Pimozide in monosymptomatic psychosis

1 reference

12 December 2020

Clozapine serum levels and side effects during steady state treatment of schizophrenic patients: a cross-sectional study

1 reference

12 December 2020

Two cases of "pure" or "primary" erotomania successfully treated with pimozide

1 reference

12 December 2020

Time to clozapine response in a standardized trial

1 reference

12 December 2020

Comparison of clozapine-amisulpride and clozapine-quetiapine combinations for patients with schizophrenia who are partially responsive to clozapine: a single-blind randomized study

1 reference

12 December 2020

Pimozide in delusions of parasitosis

1 reference

12 December 2020

Pimozide augmentation for the treatment of schizophrenic patients who are partial responders to clozapine

1 reference

12 December 2020

Identifiers

DOI

10.1038/NPP.2011.14

1 reference

Dimensions Publication ID

4 August 2017

0 references

1 reference

4 August 2017

1 reference